Literature DB >> 33984052

Correction: Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans.

.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0248080.].

Entities:  

Year:  2021        PMID： 33984052      PMCID： PMC8118240          DOI： 10.1371/journal.pone.0251897

Source DB:  PubMed          Journal:  PLoS One        ISSN： 1932-6203            Impact factor:   3.240


The twenty-eighth author’s name is spelled incorrectly. The correct name is: Weiming Xia. The publisher apologizes for the error.
  1 in total

1.  Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans.

Authors:  Catherine G Derington; Jordana B Cohen; April F Mohanty; Tom H Greene; James Cook; Jian Ying; Guo Wei; Jennifer S Herrick; Vanessa W Stevens; Barbara E Jones; Libo Wang; Alexander R Zheutlin; Andrew M South; Thomas C Hanff; Steven M Smith; Rhonda M Cooper-DeHoff; Jordan B King; G Caleb Alexander; Dan R Berlowitz; Faraz S Ahmad; M Jason Penrod; Rachel Hess; Molly B Conroy; James C Fang; Michael A Rubin; Srinivasan Beddhu; Alfred K Cheung; Weiming Xian; William S Weintraub; Adam P Bress
Journal:  PLoS One       Date:  2021-04-23       Impact factor: 3.752
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.